SciSparc Investor Presentation — February 2022

Document content

February 2022This presentation ofSciSparc Ltd.(the“Company”)contains“forward -looking statements ”within the meaning ofthe Private Securities Litigation Reform Actand other

securities laws .Words such as“expects,”“anticipates, ”“intends,”“plans,”“believes,”“seeks,”“estimates ”and similar expressions orvariations ofsuch words areintended

toidentify forward -looking statements .Forexample, theCompany isusing forward -looking statements when itdiscusses statements relating toitsobjectives, plans, and

strategies, the expected timing oftrials, itsproduct pipeline, theresearch, development, and use ofitsplatform technologies, products and product candidates, and all

statements (other than statements ofhistorical facts) that address activities, events, ordevelopments that theCompany intends, expects, projects, believes, oranticipates

will ormay occur inthe future .Forward -looking statements are not historical facts, and are based upon management ’scurrent expectations, beliefs and projections,

many ofwhich, bytheir nature, areinherently uncertain .Such expectations, beliefs and projections areexpressed ingood faith .However, there can benoassurance that

management ’sexpectations, beliefs and projections willbeachieved and actual results may differ materially from what isexpressed inorindicated bytheforward -looking

statements .Forward -looking statements aresubject torisks and uncertainties that could cause actual performance orresults todiffer materially from those expressed in

the forward -looking statements .Foramore detailed description oftherisks and uncertainties affecting theCompany, reference ismade tothe Company’sreports filed

from time totime with theSecurities and Exchange Commission including, butnotlimited to,therisks detailed intheCompany’sannual report onForm 20-Ffortheyear

ended December 31,2020.Forward -looking statements speak only asofthedate thestatements aremade .The Company assumes noobligation toupdate forward -looking

statements toreflect actual results, subsequent events orcircumstances, changes inassumptions orchanges inother factors affecting forward -looking information except to

theextent required byapplicable securities laws .IftheCompany does update one ormore forward -looking statements, noinference should bedrawn that theCompany will

make additional updates with respect thereto orwith respect toother forward -looking statements .SAFE HARBOR STATEMENT

We are revolutionizing cannabinoid -base d

treatments by developing proprietar y pharmaceuticals

that increase patients’safety byreducing doses whil e

maintaining effectiveness

3•Market Cap: $16.3 *

•Shares Outstanding: 3.1M